Three of the Rad family proteins, Rad9, Rad1, and Hus1, can interact with each other and form a heterotrimeric complex that is thought to play a role in the sensing step of the DNA integrity checkpoint pathways, but the nature of the Rad9-Rad1-Hus1 complex assembly remains enigmatic. Here, we demonstrate that the human hRad1 protein plays a significant role as molecular chaperone in the process of the hRad9-hRad1-hHus1 heterotrimeric complex formation. In contrast to hRad1, hHus1 is an unstable protein that is actively degraded via the ubiquitin-proteasome pathway. We show that treating cells with proteasome-specific inhibitors stabilizes hHus1 expression. Moreover, hRad1 can associate with hHus1 in the absence of hRad9 and protect hHus1 from ubiquitination and degradation in the cytoplasm. Importantly, genotoxic stress induces hRad1 expression and stabilizes the hHus1 protein. Taken together, these findings suggest a novel role of hRad1 as a potential intrinsic chaperone in the stabilization of hHus1 for the hRad9-hRad1-hHus1 checkpoint complex formation.
Introduction
Eukaryotic cells are continuously assaulted by intrinsic and extrinsic stress that damages genomic DNA. To maintain genomic integrity and distribute accurate copies of the genomes to the next generation, cells have evolved a core surveillance machinery with a set of signal pathways called cell cycle checkpoints consisting of damage sensors, signal transducers, and effecters (Zhou and Elledge, 2000; Melo and Toczyski, 2002) . Once damage is sensed on the genomic DNA through unknown mechanisms, the signal transducers, such as ATM and ATR, become activated in order to transmit damage signals to downstream effectors, such as chk1 and chk2, which target cell cycle machinery to inhibit cell cycle progression and provide extra time for the damage to be repaired or activate cell death machinery to induce apoptosis when the damage is too severe to survive or when repair is unfavorable. Defects in the checkpoint signaling pathways can lead to genomic instability, which is one of the major factors associated with cancer progression and other genetic disease development.
Although the DNA damage sensors are currently unclear, a group of four conserved Rad family proteins, Rad1, Rad9, Rad17, and Hus1, is thought to play an essential role in sensing the aberrant DNA structures and initiating the checkpoint signaling pathways in response to DNA damage or inhibition of DNA synthesis (Zhou and Elledge, 2000; Melo and Toczyski, 2002) . Three of these proteins, Rad1, Rad9, and Hus1, share sequence similarity with proliferating cell nuclear antigen (PCNA), a DNA polymerase processivity factor, and can assemble into a doughnut-like heterotrimeric protein complex in a head-to-tail manner that is predicted of a checkpoint-sliding clamp to monitor aberrant DNA structures (O'Connell et al., 2000) . The PCNA toroidal homotrimer is loaded onto chromatin by the clamp loader replication factor C heteropentamer (RFC1-5) during DNA replication, recombination, and repair (Tsurimoto, 1999) . Surprisingly, the fourth Rad family member, Rad17, bears structural similarity to RFC and can associate with the four small subunits of RFC to form the checkpoint clamp loader Rad17-RFC2-5 for loading of the Rad9-Rad1-Hus1 checkpoint-sliding clamp onto damaged DNA (Griffiths et al., 1995; Venclovas and Thelen, 2000; Bermudez et al., 2003; Majka and Burgers, 2003) . In support of this model, loss of Rad17 has been shown to prevent DNAdamage-induced recruitment of the Rad9 checkpoint complex onto chromatin (Zou et al., 2002; Wang et al., 2003) . Therefore, Rad1, Rad9, Hus1, and Rad17 may serve as DNA damage sensors that form a DNA damage-responsive complex clamped around the damaged DNA to transduce the damage signal to downstream effectors. The nature of the Rad9 checkpoint complex assembly, however, remains to be precisely investigated, although each member of this checkpoint complex (Rad1, Rad9, Hus1, and Rad17) has been shown to be phosphorylated in response to DNA damage or replication inhibition (St Onge et al., 1999 Bao et al., 2001; Chen et al., 2001; Post et al., 2001; Yoshida et al., 2002 Yoshida et al., , 2003 Foray et al., 2003; Roos-Mattjus et al., 2003) . In mammalian cells, the nuclear localization of the hRad9-hRad1-hHus1 checkpoint complex is dependent on a nuclear localization signal (NLS) located in the C-terminus of the hRad9 protein (Hirai and Wang, 2002) . Moreover, when DNA damage is too severe to survive, hRad9 undergoes a caspase-3-dependent proteolysis that could serve as an indirect method of halting DNA repair via disruption of the hRad9-hRad1-hHus1 complex (Lee et al., 2003) .
Molecular chaperones consist of various proteins including the families of heat-shock proteins (Fink, 1999; Frydman, 2001; Goetz et al., 2003) . These molecules mediate several cellular activities such as protein folding, maturation of protein complex, and prevention of protein aggregation and proteasomal degradation. In this report, we provide evidence showing that hRad1 may act as a molecular chaperone that inhibits hHus1 polyubiquitination and proteasomal degradation by forming a stable cytosolic hRad1-hHus1 heterodimer as a critical step in the assembly process of the hRad9-hRad1-hHus1 checkpoint-sliding clamp.
Results

Stabilization of hHus1 expression by hRad1 but not hRad9
To determine the expression of the recombinant hRad1, hRad9, and hHus1 proteins, 293T cells were transiently transfected with plasmids encoding N-terminal c-Myctagged hHus1, hRad1, or hRad9 alone, or with various combinations (2.5 mg each plasmid) as indicated in Figure 1a . The total amount of plasmid DNA was normalized to 10 mg for each transfection by adding parental control vector. At 1 day after transfection, protein extracts were prepared, normalized for total protein content (30 mg per lane), and subjected to SDS-PAGE/immunoblot analysis with anti-Myc antibody. As shown in Figure 1a , the Myc-tagged hHus1 protein was barely detected when cells transfected with hHus1 expression plasmid alone. However, the amount of the Myc-hHus1 protein was dramatically increased in cells cotransfected with either Myc-hRad1 or Myc-hRad1 and Myc-hRad9 expression plasmids. Moreover, coexpression of hRad9 had no effect on the protein levels of Myc-hHus1, indicating that the hHus1 protein is unstable in the absence of hRad1 in cells. In contrast, the protein expression of hRad1 was stable in 293T cells compared to hHus1. Interestingly, the hRad9 protein became highly modified in cells coexpressing all of these three Rad proteins compared to those observed in cells expressing hRad9 alone or together with hHus1 or hRad1.
It has been reported that the N-terminus of hHus1 interacts with the C-terminus of hRad9 (Burtelow et al., 2001) . Therefore, it is possible that the failure of hRad9 to stabilize Myc-hHus1 is due to the c-Myc tag presented in the N-terminus of hHus1 that interferes with the association between hHus1 and hRad9. To exclude this possibility, we generated and expressed pcDNA3-hHus1-Myc, which encodes the hHus1 protein with the c-Myc tag at its C-terminus, in 293T cells with or without the N-terminal Myc-tagged hRad1, hRad9, or hRad1 and hRad9 encoding plasmids ( Figure 1b) . As shown in Figure 1a and b, similar profiles of hHus1 expression and hRad9 phosphorylation were observed regardless of the c-Myc tag in N-or C-terminus of hHus1. 293T cells were transfected with the indicated combinations of 5 mg each plasmid DNA encoding the C-terminal Myc-tagged hHus1, the N-terminal Myc-tagged hRad1, or hRad9 by calcium phosphate precipitation. The total DNA amount was adjusted with pcDNA3 vector at 15 mg per transfection. The transfected cells were lysed 2 days later and 30 mg of total cell lysates were analysed by SDS-PAGE/immunoblot analysis with monoclonal antibodies specific for c-Myc epitope or a-tubulin control protein The data presented above revealed that hHus1 expression is dependent on the presence of hRad1 but not hRad9 expression. To further address this issue, we performed transfection with increasing amounts of hRad1-or hRad9-expressing plasmids with a fixed amount of hHus1 plasmid DNA. Immunoblot analysis of the transfected cells indicated that the increased expression of hRad1 ( Figure 2a ) and hRad9 ( Figure 2b ) was in direct proportion to the amount of transfected plasmid DNA. Consistently, cells transfected with MychHus1 alone had very little if any hHus1 expression (lane 1 in Figure 2a and b). Coexpression of hRad1 remarkably enhanced hHus1 expression in a concentration-dependent manner (Figure 2a ), whereas hRad9 plasmid had no effect on hHus1 expression (Figure 2b ).
Taken together, these results clearly indicate that hRad1 but not hRad9 is important for stabilization of the hHus1 protein expression.
hRad1 stabilizes hHus1 in the cytoplasm
We have previously reported that both hRad1 and hHus1 reside in the cytosol in the absence of hRad9, and that the nuclear localization of the hRad9-hRad1-hHus1 complex is dependent on the hRad9 NLS (Hirai and Wang, 2002) . To examine whether hRad1 stabilizes hHus1 in the cytoplasm, we performed fluorescent microscopic analysis. The hHus1 was expressed as a red fluorescence protein (DsRed) fusion protein in 293 cells with pIRES2-enhanced green fluorescent protein (EGFP), pIRES2-EGFP-hRad1, or pIRES2-EGFPhRad9 to produce EGFP, EGFP plus hRad1, or EGFP plus hRad9, respectively. The pIRES2-EGFP vector permits both the gene of interest and the EGFP gene to be translated from a single bicistronic mRNA for convenient differentiation of successfully transfected cells from those that did not take up and express the plasmid. As shown in Figure 3 , the red fluorescence intensity was low in 293 cells transfected with pDsRedhHus1 and pIRES2-EGFP (a-c) or pIRES2-EGFPhRad9 (g-i). However, the signal intensity of the DsRed-hHus1 fusion protein was remarkably enhanced in cells cotransfected with the pIRES2-EGFP-hRad1 plasmid DNA that produces untagged hRad1 and maker EGFP (Figure 3d-f) . Notably, the red fluorescence resulting from the DsRed-hHus1 molecules was mostly diffused in the cytoplasm. Taken together, these results indicated that hRad1 could stabilize hHus1 in the hHus1 is degraded by ubiquitin (Ub)-proteasome pathway
To determine whether protein degradation pathways contribute to the observed low levels of hHus1 protein expression, we examined a variety of protease inhibitors. As shown in Figure 4 , the 293T cells transfected with pcDNA3-Myc-hHus1 were incubated with the indicated protease inhibitors for 16 h and then subjected to immunoblotting analysis. When compared to untreated (N/C) or DMSO-treated cells, the Myc-tagged hHus1 protein accumulated distinctly in cells treated with the proteasome-specific inhibitors MG-132 and proteasome inhibitor I (PSI). However, the calpain-specific inhibitor E-64 had no effect on hHus1 expression, whereas Nacetyl-L-leucyl-L-leucyl-L-methioninal (LLM) partially protected hHus1 from degradation. Taking into account that LLM is a strong inhibitor of calpain and cathepsin but a weak inhibitor of proteasome (Rock et al., 1994) , these data indicated that the proteasome pathway may contribute to hHus1 protein degradation. Since most of proteins degraded by proteasome are conjugated with Ub, we investigated whether hHus1 could be ubiquitinated. To this end, 293T cells were transfected with pcDNA3-Myc-hHus1 with or without HA-tagged Ub expression plasmid DNA and then applied to immunoprecipitation with anti-Myc or anti-HA monoclonal antibodies. As shown in Figure 5a , immunoblot analysis with anti-HA polyclonal antiserum detected the polyubiquitinated hHus1 protein in the anti-Myc immunoprecipitates from cells transfected with HA-Ub and Myc-hHus1 but not the control pcDNA3-Myc vector. However, anti-HA immunoprecipitation confirmed the expression of HA-tagged Ub in both transfectants (Figure 5b ). These data suggested that hHus1 is constantly conjugated with poly-Ub and that this may be important for its proteasomal degradation in cells without coexpressed hRad1.
hRad1 suppresses hHus1 polyubiquitination
Based on the data presented above, we hypothesized that hRad1 protects hHus1 from proteasomal degradation through suppression of hHus1 polyubiquitination. To test this hypothesis, 293T cells were transfected with expression plasmids encoding HA-Ub and Myc-hHus1 with or without Flag-tagged hRad1. As seen in Figure 6a , cotransfection of hRad1 increased the protein levels of hHus1 as demonstrated by immunoblot analysis. Moreover, immunoprecipitation with antiMyc antibody revealed that coexpression of hRad1 apparently suppressed hHus1 polyubiquitination and stabilized the hHus1 protein (Figure 6b ). Taken together, these findings suggested that hRad1 stabilizes hHus1 expression by impeding hHus1 polyubiquitination and subsequent proteasomal degradation.
Genotoxic stress stabilizes hHus1
Finally, we examined the effects of genotoxic agents on hRad1 and hHus1 protein expression. If the hRad9-hRad1-hHus1 heterotrimer formation is a dynamic process in cell cycle checkpoint control, we reasoned that the levels of hRad1 protein should increase in order to stabilize hHus1 in response to genotoxic stress. To test this hypothesis, 293T cells transfected with Myc-hHus1 were exposed to control DMSO, 400 mM mimosine, 1 mM hydroxyurea (HU), or 50 mM etoposide (VP-16) for 16 h and subjected to SDS-PAGE/immunoblot analysis. As expected, the levels of endogenous hRad1 protein were upregulated (1.3-to 2.0-fold) in cells exposed to drugs that cause DNA damage or replication inhibition, compared with the control DMSO treated cells (Figure 7 ). It should be noted that a slowly migrating hRad1 band appeared on Western blots in damaged cells (Figure 7) , suggestive of posttranslational modifications. Concomitantly, the amounts of Myc-hHus1 protein also increased (6.0-to 6.3-fold) apparently in response to genotoxic stress (Figure 7) . These results suggest that genotoxic stress induces hRad1 expression and stabilizes hHus1 protein in order to control the dynamics of the hRad9-hRad1-hHus1 checkpoint complex formation.
Discussion
Evidence provided by molecular modeling and electron microscopic analyses has suggested that three Rad family proteins, Hus1, Rad1, and Rad9, may form a PCNA-like doughnut-shaped heterotrimeric complex (O'Connell et al., 2000; Griffith et al., 2002) . However, PCNA forms a homotrimer, whereas the Rad9-Rad1-Hus1 checkpoint complex is a heterotrimer consisting of three different proteins. This gives rise to some interesting questions such as, why is the Rad9 checkpoint complex made up of three members of the Rad family and what controls this complex formation? Why does not each of these included proteins form a PCNAlike homotrimer regardless of their structural similarities to PCNA?
In this report, we provided evidence that the stability of the hHus1 protein may play a role in the regulation of the hRad9-hRad1-hHus1 complex formation. We found that hHus1 was relatively unstable when compared to its close family members hRad1 and hRad9 in cells. The hRad1 protein is a stable molecule and its expression is not affected by hRad9 and hHus1, consistent with the findings that a large proportion of hRad1 can exist as a monomer in cells (Burtelow et al., 2001) . The stability of hHus1 expression depends upon the presence of hRad1 but not hRad9, implying that hHus1 and hRad1 may form an ordered complex prior to the association hHus1-hRad9 for the formation of the hRad9-hRad1-hHus1 checkpoint complex. Indeed, hHus1 and hRad1 can form a stable heterodimer in the cytoplasm independent of hRad9 expression (not shown). This is further supported by the genetic studies in fission yeast where a single point mutation in Hus1 that abrogates Hus1-Rad1 interaction also disrupts Hus1-Rad9 association (Kaur et al., 2001) . Moreover, it has been shown in budding yeast that the association between scRad17 (homologue of Rad1) and scMec3 (homologue of Hus1) can occur in the absence of scDdc1 (homologue of Rad9) (Kondo et al., 1999) .
These findings, that hRad1 may help stabilize hHus1, are reminiscent of molecular chaperone behaviors. Molecular chaperone helps to fold and mature target proteins, which are consequently protected from protein Figure 7 Genotoxic agents induce hRad1 expression and stabilize hHus1. The 293T cells were transiently transfected with 2 mg of pcDNA-Myc-hHus1 plasmid DNA. After 32 h of transfection, 1 mM of HU, 400 mM of mimosine, 50 mM of etoposide (VP-16), or DMSO as control was added to the cultures and incubated for further 16 h before preparation of cell lysates. A total of 30 mg cell lysates were applied to SDS-PAGE/immunoblot analysis with antibodies specific for c-Myc epitope (top), hRad1 (middle), or control a-tubulin (bottom). The immunoblotting results were quantitated and normalized by a-tubulin, and the levels of MychHus1 and endogenous hRad1 relative to those of control cells were listed Figure 6 hRad1 suppresses hHus1 polyubiquitination. The 293T cells were transfected with 0.5 mg of pcDNA3-HA-Ub plus 1 mg of pcDNA-Myc-hHus1 with ( þ ) or without (À) 1mg of pCMV2-FLAG-hRad1 plasmid DNA for 42 h before treatment with 50 mM of MG-132 for 6 h. The Myc-hHus1 protein was immunoprecipitated with anti-Myc monoclonal antibody and subjected to SDS-PAGE/immunoblot analysis together with 30 mg of total cell lysates by either of anti-Myc, anti-hRad1, or anti-HA polyclonal antibodies degradation (Fink, 1999; Frydman, 2001; Goetz et al., 2003) . Indeed, hRad1 can bind to and stabilize hHus1 probably by the suppression of hHus1 polyubiquitination. It is also possible that the binding of hRad1 to hHus1 prevents its insertion into the core of the proteasome machinery to interfere in the degradation process. Although it is not clear whether hRad1 is required to fold the nascent hHus1 peptide chain, without hRad1 chaperone the hHus1 protein undergoes a rapid degradation via Ub-proteasome pathways.
Based on these data, we propose a model for the hRad9-hRad1-hHus1 checkpoint complex formation. As shown in Figure 8 , hHus1 and hRad1 can form a cytosolic heterodimer independent of hRad9. If hHus1 is excessively produced, the extra hHus1 protein undergoes a rapid degradation via Ub-proteasome pathways. The hRad1-hHus1 heterodimer is stable and subsequently translocates into the nucleus upon its association with hRad9 containing a C-terminal NLS. Through this process, a quality-controlled hRad9-hRad1-hHus1 checkpoint complex is formed and loaded onto chromatin by the hRad17-RFC2-5 clamp loader when DNA damage is recognized. Indeed, genotoxic stress could upregulate hRad1 and hHus1 (Figure 7 ), although it is not certain whether the increases in hRad1 protein level directly translate to the protein stability of hHus1. At the present time, we cannot exclude the existence of other mechanisms involved in the suppression of the protein degradation of hHus1. Anyhow, our findings suggest a possibility that hHus1 may work as a molecular sensor for DNA stress.
The Ub-proteasome system is at the center of cellular proteolysis that controls numerous cellular processes including cell cycle checkpoint and DNA repair (McBride et al., 2003) . It has been shown that proteasome inhibitors are able to activate cell cycle checkpoint signaling pathways at G1/S, S and G2/ M phases (Bendjennat et al., 2003; McBride et al., 2003) .
Interestingly, the DNA polymerase-sliding clamp PCNA is conjugated with Ub and this modification is important for its function in the process of DNA repair (Hoege et al., 2002) . Although the physiological meanings of hHus1 polyubiquitination need to be further studied, the work described here provides the first evidence that the hHus1-Ub conjugation may contribute to the control of cell cycle checkpoints.
Materials and methods
Expression plasmids and reagents
The pcDNA3-Myc-hRad9, pcDNA3-Myc-hRad1, and pcDNA3-Myc-hHus1 plasmids were described previously (Hirai and Wang, 2002) . The plasmid pcDNA3-hHus1-Myc encoding the hHus1 protein with the c-Myc tag at its carboxylterminus was constructed by PCR. To produce HA-tagged Ub or hRad1, the cDNA fragments encoding Ub or hRad1 were cloned in frame into pcDNA3-HA vector. The pIRES2-EGFP-hRad1 and pIRES2-EGFP-hRad9 vectors express EGFP with untagged hRad1 and hRad9, respectively. To produce red fluorescent protein (DsRed)-fused hHus1 protein, the hHus1 cDNA was cloned in frame into the EcoRI/SalIdigested pDsRed-C vector (Clontech). MG-132, E-64 and LLM were purchased from Sigma and PSI was from Calbiochem. Anti-FLAG M2 monoclonal antibody, anti-HA polyclonal antibody, and anti-a-tubulin monoclonal antibody were purchased from Sigma. Anti-c-Myc polyclonal antibody was obtained from Santa Cruz Biotechnology.
Cell culture and transfection
The 293 and 293T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and antibiotics. Transfections were carried out with a total of 10 mg of plasmid DNA for 1-2 Â 10 6 cells by a calcium phosphate precipitation method or a total of 2.5-3 mg of plasmid DNA for 0.5 Â 10 6 cells by TransIT-LT1 reagent (Mirus) according to the respective manufacture's recommendations.
Immunoblot, immunoprecipitation, and fluorescent microscopy
Immunoblot and immunoprecipitation were carried out as described previously (Hirai and Wang, 2002) with minor modifications. Briefly, cells were lysed in an appropriate volume of 0.5% Triton X-100 lysis buffer (10 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM EDTA, 10% glycerol, and 0.5% Triton X-100) with protease inhibitors after 48 h of transfection. For fluorescence microscopic analysis, cells were grown on coverslips in 35 mm dishes overnight and transfected with the indicated plasmid DNA for 2 days. The cells were then washed twice in phosphate-buffered saline, fixed in 3.7% formaldehyde for 30 min, permeabilized in 0.5% Triton X-100 for 15 min, and mounted in Vectashield mounting medium with DAPI (Vector Labs) for analysis with a fluorescence microscope.
Ubiquitination assay
The 293T cells were transfected with a mixture of pcDNA3-HA-Ub and pcDNA3-Myc-hHus1 with or without pCMV2-FLAG-hRad1. After 42 h of transfection, the proteasome inhibitor MG-132 was added to the cells at a final concentration of 50 mM, and then the cells were incubated for additional 6 h before collection. The cell lysate was prepared in 0.5% Figure 8 A model of the hRad9-hHus1-hRad1 complex formation. In the cytoplasm, hHus1 forms an ordered complex with hRad1 prior to its association with hRad9. The rest hHus1 undergoes a rapid degradation via Ub-proteasome pathways, whereas the hHus1-hRad1 heterodimer binds to hRad9 and subsequently translocates into the nucleus where this hRad9-hRad1-hHus1 heterotrimer functions as a checkpoint-sliding clamp in response to DNA damage or replication inhibition Rad1 stabilizes Hus1 I Hirai et al Triton X-100 lysis buffer containing 5 mM of N-ethylmaleimide as Ub-isopeptidase inhibitor and used for immunoblotting and immunoprecipitation. Immunoprecipitation was carried out with anti-c-Myc monoclonal antibody, and the polyubiquitinated hHus1 was detected with anti-HA polyclonal antibody.
